Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for VSTM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 -0.026M
March 31, 2026 -29.41M
December 31, 2025 -98.77M
September 30, 2025 -18.16M
June 30, 2025 -79.69M
March 31, 2025 -34.27M
December 31, 2024 -0.875M
September 30, 2024 -53.84M
June 30, 2024 -0.136M
March 31, 2024 -0.085M
December 31, 2023 0.00
September 30, 2023 0.458M
June 30, 2023 -91.91M
March 31, 2023 -28.13M
December 31, 2022 0.00
September 30, 2022 -25.62M
June 30, 2022 -1.332M
March 31, 2022 -0.68M
December 31, 2021 -6.804M
September 30, 2021 -0.188M
June 30, 2021 -0.518M
March 31, 2021 -0.30M
December 31, 2020 -1.045M
September 30, 2020 -0.137M
June 30, 2020 -12.68M
Date Value
March 31, 2020 -95.18M
December 31, 2019 0.00
September 30, 2019 -0.494M
June 30, 2019 0.00
March 31, 2019 -0.075M
December 31, 2018 -0.172M
September 30, 2018 -0.074M
June 30, 2018 -105.42M
March 31, 2018 -0.299M
December 31, 2017 -34.30M
September 30, 2017 -14.21M
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 -0.051M
September 30, 2015 -0.226M
June 30, 2015 -8.152M
March 31, 2015 -55.57M
December 31, 2014 -9.542M
September 30, 2014 -0.001M
June 30, 2014 0.00
March 31, 2014 -0.011M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. -10.49M
Dianthus Therapeutics, Inc. -10.38M
Alnylam Pharmaceuticals, Inc. -33.56M
Anika Therapeutics, Inc. 0.643M
Savara, Inc. -0.189M